Affidea

Affidea Affidea is the pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider.

About Affidea
-nothing is more important than health
Affidea is the pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider. Founded in 1991, the company operates 358 centres across 15 countries, providing high-quality medical services to nearly 13 million patients every year. Due to its track record for patient safety, the company has become the

most awarded diagnostic imaging provider in Europe by the European Society of Radiology, as over 80% of the centres recognised on the Eurosafe Wall of Stars belong to Affidea. Affidea is majority-owned by Groupe Bruxelles Lambert (GBL), a leading investment holding company, focused on long-term value-creation with a stable and supportive family shareholder base.

26/08/2026

At Affidea, is part of our DNA. It is embedded in our values, as well as in our strategy: using technology, clinical expertise and smarter ways of working to make more , more and more relevant to every patient.

For us, innovation is not about adopting technology for the sake of it. It is about creating solutions that genuinely improve the experience and outcomes of the people we care for, while supporting clinicians to make better decisions and enabling our teams to deliver care more effectively.

In this short video, Dr Johann Alberts, Affidea’s Chief Digital Solutions Officer, explains how we translate into real value by looking at it through three interconnected lenses: clinical impact, economic sustainability and operational feasibility.

The starting point is always clinical: does the innovation help clinicians, improve decision-making and enhance safety? But for innovation to scale and ultimately benefit more patients, it also needs to be economically sustainable and work in real-life operations.

This is how innovation becomes more than an idea — it becomes an enabler of the personalised, patient-centred care we deliver across Affidea.

🎥 Watch Johann Albert’s perspective on how we turn innovation into meaningful impact for patients, clinicians and healthcare systems.

26/08/2026

At Affidea, is part of our DNA. It is embedded in our values, as well as in our strategy: using technology, clinical expertise and smarter ways of working to make more , more and more relevant to every patient.

For us, innovation is not about adopting technology for the sake of it. It is about creating solutions that genuinely improve the experience and outcomes of the people we care for, while supporting clinicians to make better decisions and enabling our teams to deliver care more effectively.

In this short video, Dr Johann Alberts, Affidea’s Chief Digital Solutions Officer, explains how we translate into real value by looking at it through three interconnected lenses: clinical impact, economic sustainability and operational feasibility.

The starting point is always clinical: does the innovation help clinicians, improve decision-making and enhance ? But for innovation to scale and ultimately benefit more patients, it also needs to be economically sustainable and work in real-life operations.

This is how innovation becomes more than an idea — it becomes an enabler of the , patient-centred care we deliver across Affidea.

🎥 Watch Johann Albert's perspective on how we turn into meaningful impact for patients, clinicians and healthcare systems.

A new milestone in Affidea's UK journey!We are proud to announce our strategic partnership with LIPS Healthcare (Londo...
23/07/2026

A new milestone in Affidea's UK journey!

We are proud to announce our strategic partnership with LIPS Healthcare (London International Patient Services), the UK's largest private consultant-led multi-specialty group.

As part of this partnership, Affidea will co-invest alongside LIPS Healthcare in a state-of-the-art 40,000 sq ft multi-specialty clinic, located on Prince of Wales Drive, London, due to break ground later this year, as well as in the extension of the existing Battersea Power Station Clinic. This will enable the business to expand its footprint, strengthen its diagnostic and treatment capabilities, and continue building an ecosystem where leading consultants can collaborate, innovate and continue delivering high-quality care for patients.

Affidea’s investment marks an important step in its UK growth strategy, strengthening its presence in one of Europe’s most dynamic private healthcare markets.

As we continue to grow our UK presence, this marks another important step in delivering accessible, integrated healthcare closer to patients and supporting the next generation of out-of-hospital care.

Read the full announcement in the article here: https://bit.ly/Affidea_Partnership_LIPS

13/07/2026

is evolving faster than ever. New technologies, artificial intelligence and digital transformation are reshaping the way we diagnose, treat and support our patients. But technology alone is not enough. The real difference comes from healthcare professionals who continuously learn, adapt and grow alongside these advancements.

At Affidea, we believe that clinical excellence is built through continuous education, scientific collaboration and . By investing in clinical knowledge, digital skills and continuous professional development, we empower healthcare professionals to deliver the highest standards of patient while preparing for the future of healthcare. 💙

Watch the video with Dr Rosana Santos, Affidea Group Clinical Education Scientific Leader, as she explains why continuous is one of the most important foundations for the future of healthcare.

Advancing clinical expertise also means staying connected to the latest scientific dialogue. We were proud to have our t...
29/06/2026

Advancing clinical expertise also means staying connected to the latest scientific dialogue. We were proud to have our team represented at the 37th Annual Meeting and Postgraduate Course of in Montpellier, France, one of the leading international forums dedicated to and .

Affidea was represented by Dr Athanasia (Nasia) Papachristodoulou, who had the opportunity to engage with leading experts from around the world, explore the latest advances in abdominal radiology, artificial intelligence, oncologic imaging, and image-guided therapies, and exchange knowledge on emerging trends that are shaping the future of patient care.

Reflecting on the experience, Nasia noted: "Attending was an inspiring experience that reinforced the importance of continuous learning, innovation, and international collaboration. Bringing new knowledge and perspectives back to our daily practice is essential to delivering the highest quality of care to our patients."

Dr Palko Andras, a member of Affidea’s Medical Advisory Board, represented Affidea at , bringing his extensive expertise in gastrointestinal and abdominal radiology to the scientific exchange, further strengthening our company’s presence within the global radiology community.

Dr Palko stated: "ESGAR continues to set the benchmark for excellence in gastrointestinal and abdominal radiology. The opportunity to exchange knowledge with leading international experts and discuss the latest developments in our field is invaluable for advancing both clinical practice and patient care."

Participation in high-level scientific meetings such as ESGAR reflects our ongoing commitment to professional excellence, continuous , , and the delivery of the highest standards of diagnostic imaging services.

At Affidea, we believe that the way our managers lead shapes the way our teams feel, collaborate and perform. This is wh...
18/06/2026

At Affidea, we believe that the way our managers lead shapes the way our teams feel, collaborate and perform. This is why, three years ago, we launched the Affidea Core Program: a dedicated learning journey designed to strengthen leadership from the inside out.

This week, we proudly completed the 3rd edition of the programme, bringing together 41 Affidea key leaders from across our countries for four months of learning, reflection and exchange. Throughout the programme, participants deepened their understanding of their own leadership style and worked on essential capabilities including strategic thinking, communication, delegation and team development, both individually and in groups.

Just as importantly, the programme created space for leaders from different countries to connect, share experiences and build a stronger network across Affidea, while spending time together in Madrid.

As Eduardo Blazquez Gomez, Chief HR Officer at Affidea Group, said: “The Core Leadership Program reflects our commitment to developing strong managers across Affidea markets. By investing in their , we are strengthening the way our teams work together, communicate and deliver on our shared ambitions.”

Thank you to all our managers for their commitment, openness and energy over the past months, and to our Corporate HR team for their continued dedication to people development across Affidea. We are already looking forward to the 4th edition. 👏

As medical becomes more powerful, adaptive and multimodal, the question is no longer whether it can transform healthca...
17/06/2026

As medical becomes more powerful, adaptive and multimodal, the question is no longer whether it can transform healthcare, but how healthcare providers ensure it reaches patients safely, responsibly and at scale.

Dr Alessandro Roncacci, SVP Chief Medical Officer at Affidea Group, participated in the Conference, on the panel “Fast technology, slow systems: who pays the price?”, organised by United Imaging Healthcare and moderated by Fernando J. Erazo, Vice President, United Imaging Europe.

The discussion focused on one of the most important topics today: AI is evolving faster than the regulatory frameworks designed to govern it. As medical AI moves from narrow, point-solution algorithms towards adaptive, multimodal platforms capable of supporting multiple clinical indications, the challenge is no longer only how to approve AI, but how to implement it safely, responsibly and at scale.

As Alessandro Roncacci highlighted during the discussion: “Success in medical will not be measured by how many algorithms are approved, but by how many are safely embedded into clinical workflows and demonstrably improve , , and clinician experience. AI adoption is not only a technology project, it is a clinical transformation project. To bring its benefits to patients faster, we need governance, local validation, clinical ownership and continuous monitoring to evolve together. At Affidea, we believe the future of AI in healthcare depends on the ability to combine with responsibility. Regulatory approval is only the beginning. Real impact happens when AI is integrated into daily clinical practice, trusted by clinicians, understood by patients, and continuously monitored in real-world settings.”

With a network spanning multiple countries, modalities, equipment, workflows and patient populations, Affidea is committed to helping generate the real-world evidence needed to support safe, scalable and meaningful AI adoption across Europe.

Some contributions change the way we work, not just what we do.This month, we are proud to recognise Paulė Sadauskaitė f...
16/06/2026

Some contributions change the way we work, not just what we do.

This month, we are proud to recognise Paulė Sadauskaitė from Affidea Lietuva (Lithuania) as our Affidea European Employee of the Month for May 2026.

Working at our Kaunas clinic, Paulė has gone beyond her core role to make a real difference in how doctors join and experience our organisation. She has been actively involved in strengthening doctor onboarding, improving internal communication and helping build a stronger, more connected medical culture.

Her contribution is not just operational. It directly impacts how new doctors integrate, collaborate and deliver care, ultimately supporting both employee experience and quality standards.

What stands out is her initiative. From supporting internal doctor discussions to contributing to the development of onboarding practices, Paulė consistently looks for ways to make things work better - for colleagues, for teams and for the organisation as a whole.

The recognition was personally presented by our Group CHRO, Eduardo Blazquez Gomez, during a visit to Lithuania, together with leaders from across 14 countries, making this moment even more special.

Thank you, Paulė, for your energy, ownership and the impact you create every day. 💙

A new chapter for community-based healthcare in Wimbledon is taking shape.Barry Downes, CEO Affidea UK & Ireland, and Dr...
15/06/2026

A new chapter for community-based healthcare in Wimbledon is taking shape.

Barry Downes, CEO Affidea UK & Ireland, and Dr Charles Niehaus, Executive Director of Affidea Group, recently visited our new Affidea Outpatient Clinic, currently under construction in Wimbledon Quarter, to see the progress first-hand.

Opening in autumn 2026 within Quarter, the new 30,000 sq. ft. Affidea Clinic will introduce a more and model of private healthcare for the local community. Designed as a modern, single-level environment, the centre will bring , connected care closer to where people live, work and shop — supporting Affidea’s ambition to make high-quality healthcare easier to access and more seamlessly connected around patients.

The clinic will offer a comprehensive range of services under one roof, including private GP care, urgent care and minor injuries, advanced diagnostic imaging, specialist outpatient consultations, endoscopy and state-of-the-art surgical facilities.

It was great to see the progress already being made, with consultation rooms nearing completion and the theatre block taking shape. A big thank you to the teams working hard to bring this important project to life.

We are excited for what is ahead and for the opportunity to welcome our first patients later this year.

We are pleased to announce that Guy Blomfield, Group CEO and Chairman of the Management Board of Affidea, will speak at ...
08/06/2026

We are pleased to announce that Guy Blomfield, Group CEO and Chairman of the Management Board of Affidea, will speak at the 2nd edition of the in Private Capital , organised in association with the European Healthcare Investor Association (E.H.I.A.)

As part of a dedicated case-study session, Guy will share Affidea’s experience in building an integrated model of Out-of-Hospital, community-based , exploring the strategies, outcomes and lessons learned from its real-world implementation in 420 clinics across 15 countries in Europe.

The presentation will also offer insights into the market trends shaping the , followed by an interactive Q&A with participants, moderated by Ian Poburenny, Director at Rothschild.

We look forward to contributing to an important conversation about how innovation and new models of can help create more , and healthcare, delivered closer to the communities and patients we serve. 💙

📅 16 June 2026
📍 Institute of Directors, London
▶️ More information about the conference: https://lnkd.in/eRJie4fC

With: Henry Elphick, Ian Poburenny, Guy Blomfield

Adres

Zuid Hollandlaan 7
Amsterdam
1017HL

Website

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Affidea nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar Affidea:

Snelkoppelingen

Uitgelicht

Delen

Type